Sacramento Chinese Culture Foundation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2021 Annual Report
JBM (Healthcare) Limited Incorporated in the Cayman Islands with limited liability Stock Code: 2161 Movement inspires Annual Report 2021 Corporate Information BOARD OF DIRECTORS AUTHORISED REPRESENTATIVES AUDITOR Executive Directors Mr. Wong Yat Wai, Patrick KPMG Mr. Wong Yat Wai, Patrick Dr. Chu Ka Wing Certified Public Accountants (Chief Executive Officer) Public Interest Entity Auditor Dr. Chu Ka Wing COMPANY SECRETARY registered in accordance with the Financial Reporting Council Ms. Au Man Yee, Teresa Non-executive Directors Ordinance Mr. Sum Kwong Yip, Derek REGISTERED OFFICE COMPLIANCE ADVISOR (Chairman) Cricket Square Ping An of China Capital Mr. Yim Chun Leung Hutchins Drive (Hong Kong) Company Limited Mr. Yeung Kwok Chun, Harry PO Box 2681 Grand Cayman KY1-1111 PRINCIPAL BANKERS Independent Non-executive Cayman Islands (In alphabetical order) Directors Chong Hing Bank Limited Mr. Chan Kam Chiu, Simon HONG KONG HEADQUARTERS AND Standard Chartered Bank Mr. Luk Ting Lung, Alan PRINCIPAL PLACE OF BUSINESS (Hong Kong) Limited Mr. Lau Shut Lee, Tony Unit 2303-07, 23/F The Hongkong and Shanghai Tower 1, Millennium City 1 Banking Corporation Limited 388 Kwun Tong Road AUDIT COMMITTEE Kwun Tong, Kowloon PUBLIC RELATIONS CONSULTANT Mr. Chan Kam Chiu, Simon Hong Kong Strategic Public Relations Group (Chairman) Mr. Luk Ting Lung, Alan PRINCIPAL SHARE REGISTRAR INVESTOR RELATIONS Mr. Lau Shut Lee, Tony AND TRANSFER OFFICE Email: [email protected] Conyers Trust Company REMUNERATION COMMITTEE (Cayman) Limited STOCK CODE 2161 Mr. Luk Ting Lung, Alan Cricket Square (Chairman) Hutchins Drive COMPANY WEBSITE Mr. Yim Chun Leung PO Box 2681 www.jbmhealthcare.com.hk Mr. Chan Kam Chiu, Simon Grand Cayman KY1-1111 Mr. -
LEE BIAO LING A.K.A
IP PHL LEE BIAO LING a.k.a. GRACE LEE, } IPC No. 14-2010-00007 Opposer, } Opposition to: } Appln. Serial No. 4-2009-002892 -versus- } Date Filed: 20 March 2009 QUINWOOD LIMITED, } TM: PO CHAI PILLS IN Respondent-Applicant } CHINESE CHARACTERS y _V NOTICE OF DECISION BENGZON NEGRE UNTALAN Counsel for Opposer 2nd Floor, SEDCCO Building, Rada corner Legaspi Streets, Legaspi Village, Makati City 1229 ANGARA ABELLO CONCEPCION RAGALA & CRUZ Counsel for Respondent- Applicant 22nd Floor, ACCRALAW Tower Second Avenue corner 30th Street, Crescent Park West, Bonifacio Global City Taguig GREETINGS: Please be informed that Decision No. 2016 - S3S dated 23 December 2016 (copy enclosed) was promulgated in the above entitled case. Pursuant to Section 2, Rule 9 of the IPOPHL Memorandum Circular No. 16-007 series of 2016, any party may appeal the decision to the Director of the Bureau of Legal Affairs within ten (10) days after receipt of the decision together with the payment of applicable fees. Taguig City, 06 January 2017. MARILYN F. RETUTAL IPRS IV Bureau of Legal Affairs Republic of the Philippines INTELLECTUAL PROPERTY OFFICE Intellectual Property Center # 28 Upper McKinley Road, McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines •www.ipophil.qov.ph T: +632-2386300 • F: +632-5539480 »[email protected] IP PHL OFFICE OF THE PHILIPPINES LEE BIAO LING a.k.a. GRACE LEE, } IPC No. 14-2010-000007 Opposer, } } Opposition to: -versus- } Application No. 4-2009-002892 Date Filed: 20 March 2009 } Trademark: "PO CHAI PILLS QUINWOOD LIMITED, } IN CHINESE CHARACTERS" Respondent-Applicant. } x x Decision No. -
Locke Foundation Newsletter 樂居鎮基金會 Preserving Locke’S History and Legacy
Locke Foundation Newsletter 樂居鎮基金會 Preserving Locke’s history and legacy [email protected] Fall 2020 www.locke-foundation.org Dear Friends of the Locke Foundation, Now in existence for nearly two decades, the Locke Foundation contin- ues to expand its programs, activities and offerings to the public. It is our mission to educate the public about the historic legacy of Locke and to tell the stories of California's compelling immigrant experi- ence. While Locke may be a quaint destination for a weekend drive along the meandering Sacramento River, it is a treasure trove of a by- gone era infused with whispers of human resilience and triumph over adversity. The focus on COVID-19 relief aid for urgent needs has come at the expense of smaller nonprofits, especially those supporting the arts and historical preser- vation. Already struggling to maintain operations and provide services amid the pandemic, nonprofits big and small are also facing the challenge of how to keep revenues flowing — difficult even in good times — when they can no longer count on golf tournaments, dinner galas and other charity events. COVID-19 restrictions have shut down traditional fund- raising activities for many nonprofits including the LF which had to cancel its signature events, Locke Asian Pacific Street Festival and particularly its Fall Fundraising Banquet. In order to meet our mission and provide services in our community, we rely on the gener- osity of individuals, organizations and businesses for support. Without their assistance we wouldn't be able to serve the public while accomplishing our mission goals. We ask that you make a commitment to support our annual appeal by making a cash dona- tion. -
有限公司 (Incorporated in the Cayman Islands with Limited Liability) (The “Company”) WARNING
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of JBM (HEALTHCARE) LIMITED 健倍苗苗(保健)有限公司 (Incorporated in the Cayman Islands with limited liability) (the “Company”) WARNING The publication of this Post Hearing Information Pack is required by The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Post Hearing Information Pack is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sponsor, advisers or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Stock Exchange’s website does not give rise to any obligation of the Company, its sponsor, advisers or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction. -
China Traditional Chinese Medicine Co. Limited
2014 INTERIM REPORT (Stock code: 00570) (Incorporated in Hong Kong with Limited Liability) China Traditional Chinese Medicine Co. Limited Co. Medicine Chinese Traditional China 中 國 中 藥 有 限 公 司 2014 中期報告 China Traditional Chinese Medicine Co. Limited 2014 INTERIM REPORT 2014 中期報告 司 公 中國中藥有限 CONTENTS CORPORATE INFORMATION 2 MANAGEMENT DISCUSSION AND ANALYSIS 3 OTHER INFORMATION 13 INDEPENDENT AUDITOR’S REPORT 20 CONSOLIDATED STATEMENT OF PROFIT OR LOSS 21 CONSOLIDATED STATEMENT OF PROFIT OR LOSS 22 AND OTHER COMPREHENSIVE INCOME CONSOLIDATED STATEMENT OF FINANCIAL POSITION 23 CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 25 CONDENSED CONSOLIDATED CASH FLOW STATEMENT 27 NOTES TO THE UNAUDITED INTERIM FINANCIAL REPORT 28 China Traditional Chinese Medicine Co. Limited INTERIM REPORT 2014 1 CORPORATE INFORMATION Board of Directors Executive Directors Mr. WU Xian (Chairman) Mr. YANG Bin (Managing Director) Mr. WANG Xiaochun Non-executive Directors Mr. LIU Cunzhou Mr. ZHANG Jianhui Mr. DONG Zenghe Mr. ZHAO Dongji Independent Non-executive Directors Mr. ZHOU Bajun Mr. XIE Rong Mr. FANG Shuting Mr. YU Tze Shan Hailson Company Secretary Mr. HUEN Po Wah Audit Committee Mr. XIE Rong (Chairman) Mr. ZHOU Bajun Mr. FANG Shuting Remuneration Committee Mr. ZHOU Bajun (Chairman) Mr. LIU Cunzhou Mr. XIE Rong Mr. FANG Shuting Nomination Committee Mr. WU Xian (Chairman) Mr. YANG Bin Mr. ZHOU Bajun Mr. XIE Rong Mr. FANG Shuting Strategic Committee Mr. LIU Cunzhou (Chairman) Mr. WU Xian Mr. YANG Bin Mr. WANG Xiaochun Mr. ZHOU Bajun Mr. YU Tze Shan Hailson Registered Office Room 1601, Emperor Group Building 288 Hennessy Road, Wanchai Hong Kong Auditors KPMG Certified Public Accountants Hong Kong Share Registrar and Computershare Hong Kong Investor Services Limited Transfer Office Shop 1712-16 17th Floor, Hopewell Centre 183 Queen’s Road East Wanchai Hong Kong Principal Bankers Bank of China (Hong Kong) Limited Bank of China Limited Macau Branch Industrial and Commercial Bank of China Limited (Foshan Branch) China Merchants Bank Co., Ltd. -
Jacobson Pharma Corporation Limited 雅各臣科研製藥有限公司 (The “Company”) (Incorporated Under the Laws of the Cayman Islands with Limited Liability) WARNING
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Jacobson Pharma Corporation Limited 雅各臣科研製藥有限公司 (the “Company”) (Incorporated under the laws of the Cayman Islands with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Exchange”)/the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sponsor, advisers or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Exchange’s website does not give rise to any obligation of the Company, its sponsor, advisers or members of the underwriting syndicate to proceed with an offering in Hong -
QUINWOOD-LIMITED-Vs
IP INTELLECTUAL PROPERTY OFFICE OF THE PHILIPPINES QUINWOOD LIMITED, } IPCNo. 14-2009-00149 Opposer, } Opposition to: } Appln. Serial No. 4-2008-011238 } Date Filed: 16 September 2008 -versus- } TM: "JIN LING BAO PILL } Package Label Mark" } } LEE BIAO LING a.k.a. GRACE LEE, } Respondent- Applicant. } x— ~x NOTICE OF DECISION ANGARA ABELLO CONCEPCION REGALA & CRUZ Counsel for Opposer 22nd Floor, ACCRALAW Tower Second Avenue corner 30th Street Crescent Park West Bonifacio Global City Taguig BENGZON NEGRE UNTALAN Counsel for Respondent- Applicant Second Floor SEDCCO Bldg., Rada cor. Legaspi Streets Legaspi Village, Makati City GREETINGS: Please be informed that Decision No. 2016 - T w dated December 20, 2016 (copy enclosed) was promulgated in the above entitled case. Pursuant to Section 2, Rule 9 of the IPOPHL Memorandum Circular No. 16-007 series of 2016, any party may appeal the decision to the Director of the Bureau of Legal Affairs within ten (10) days after receipt of the decision together with the payment of applicable fees. Taguig City, December 20, 2016. MARILYN F. RETUTAL IPRS IV Bureau of Legal Affairs Republic of the Philippines INTELLECTUAL PROPERTY OFFICE Intellectual Property Center # 28 Upper McKinley Road, McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines •www.ipophil.aov.ph T: +632-2386300 • F: +632-5539480 • [email protected] JFFICE OF THE PHILIPPINES QUINWOOD LIMITED, }IPC NO. 14-2009-00149 Opposer, }Opposition to: }Appln. Ser. No. 4-2008-011238 -versus- }Date Filed: 16 September 2008 }Trademark : JIN LING BAO LEE BIAO LING a.k.a. GRACE LEE, } PILL Package Label Mark Respondent-Applicant. -
Global Offering
Pharma Corporation Jacobson Pharma Corporation Limited 雅各臣科研製藥有限公司 (Incorporated under the laws of the Cayman Islands with limited liability) Stock Code : 2633 GLOBAL OFFERING Sole Global Coordinator Sole Sponsor Sole Bookrunner and Sole Lead Manager IMPORTANT IMPORTANT: If you are in any doubt about the contents of this prospectus, you should seek independent professional advice. Pharma Corporation Jacobson Pharma Corporation Limited 雅各臣科研製藥有限公司 (Incorporated under the laws of the Cayman Islands with limited liability) GLOBAL OFFERING Number of Offer Shares under the : 437,500,000 Shares (subject to the Global Offering Over-allotment Option) Number of Hong Kong Offer Shares : 43,752,000 Shares (subject to adjustment) Number of International Offer Shares : 393,748,000 Shares (subject to adjustment and the Over-allotment Option) Maximum Offer Price : HK$1.72 per Offer Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027% and Hong Kong Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars, subject to refund) Nominal value : HK$0.01 per Share Stock code : 2633 Sole Sponsor, Sole Global Coordinator, Sole Bookrunner and Sole Lead Manager Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in the section headed “Documents Delivered to the Registrar of Companies and Available for Inspection” in Appendix VI to this prospectus, has been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). -
JBM (HEALTHCARE) LIMITED ( 保健 JBM (HEALTHCARE) LIMITED ) 有限公司 健倍苗苗(保健)有限公司 (Incorporated in the Cayman Islands with Limited Liability) Stock Code: 2161
健倍苗苗 LIMITED JBM (HEALTHCARE) ( 保健 JBM (HEALTHCARE) LIMITED ) 有限公司 健倍苗苗(保健)有限公司 (Incorporated in the Cayman Islands with limited liability) Stock Code: 2161 Sole Sponsor and Sole Bookrunner IMPORTANT If you are in any doubt about any of the contents of this prospectus, you should seek independent professional advice. JBM (HEALTHCARE) LIMITED 健倍苗苗(保健)有限公司 (Incorporated in the Cayman Islands with limited liability) PUBLIC OFFER Number of Offer Shares : 44,686,000 Shares Offer Price : HK$1.20 per Offer Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027% and the Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) Nominal Value : HK$0.01 per Share Stock Code : 2161 Sole Sponsor, Sole Bookrunner and Joint Lead Manager Joint Lead Managers (in alphabetical order) Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in the section headed “Documents Delivered to the Registrar of Companies and Available for Inspection” in Appendix V to this prospectus, has been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). -
S3Z Dated 23 December 2016 (Copy Enclosed) Was Promulgated in the Above Entitled Case
IP PHL JFFICE OF THE • H I LI P P I N ES LEE BIAO LING ak.a. GRACE LEE, } IPC No. 14-2010-00008 Opposer, } Opposition to: } Appln. Serial No. 4-2009-002893 -versus- } Date Filed: 20 March 2009 QUINWOOD LIMITED, } TM: PO CHAI PILLS Respondent-Applicant. } v NOTICE OF DECISION BENGZON NEGRE UNTALAN Counsel for Opposer 2nd Floor, SEDCCO Building, Rada corner Legaspi Streets, Legaspi Village, Makati City 1229 ANGARA ABELLO CONCEPCION RAGALA & CRUZ Counsel for Respondent- Applicant 22nd Floor, ACCRALAW Tower Second Avenue corner 30th Street, Crescent Park West, Bonifacio Global City Taguig GREETINGS: Please be informed that Decision No. 2016 - S3Z dated 23 December 2016 (copy enclosed) was promulgated in the above entitled case. Pursuant to Section 2, Rule 9 of the IPOPHL Memorandum Circular No. 16-007 series of 2016, any party may appeal the decision to the Director of the Bureau of Legal Affairs within ten (10) days after receipt of the decision together with the payment of applicable fees. Taguig City, 06 January 2017. MARILYN F. RETUTAL IPRS IV Bureau of Legal Affairs Republic of the Philippines INTELLECTUAL PROPERTY OFFICE Intellectual Property Center # 28 Upper McKinley Road, McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines •www.ipophil.aov.ph T: +632-2386300 • F: +632-5539480 •[email protected] LEE BIAO LING a.k.a. GRACE LEE, } IPC No. 14-2010-000008 Opposer, } } Opposition to: -versus- } Application No. 4-2009-002893 } Date Filed: 20 March 2009 } Trademark: "PO CHAI PILLS" QUINWOOD LIMITED, } Respondent-Applicant. } x x Decision No. 2016- S3Z DECISION LEE BIAO LING a.k.a. -
Annual Report 2017 2017
中 國 中 中國中藥控股有限公司 藥 控 股 有 限 公 司 2017 年報 China Traditional Chinese Medicine Holdings Co. Limited Co. Holdings Medicine Chinese Traditional China 年 報 ANNUAL REPORT 2017 2017 2017 Annual Report Contents Corporate Information 2 Five Year Financial Summary 3 Chairman’s Statement 5 Management Discussion and Analysis 10 Report of the Directors 31 Corporate Governance Report 45 Biographical Details of Directors and Senior Management 60 Independent Auditor’s Report 65 Consolidated Statement of Profit or Loss and Other Comprehensive Income 71 Consolidated Statement of Financial Position 73 Consolidated Statement of Changes in Equity 75 Consolidated Statement of Cash Flows 76 Notes to the Consolidated Financial Statements 78 Corporate Information BOARD OF DIRECTORS REGISTERED OFFICE Executive Directors Room 1601, Emperor Group Centre 288 Hennessy Road Mr. WU Xian (Chairman) Wanchai Mr. WANG Xiaochun (Managing Director) Hong Kong Mr. ZHAO Dongji Ms. HUANG He Tel: (852) 2854 3393 Fax: (852) 2544 1269 Non-executive Directors Email: [email protected] Mr. LIU Cunzhou STOCK CODE Mr. YANG Shanhua Ms. TANG Hua The shares of China Traditional Chinese Medicine Holdings Co. Limited are listed on The Stock Exchange of Independent Non-executive Directors Hong Kong Limited Mr. ZHOU Bajun Stock code: 00570 Mr. XIE Rong Mr. YU Tze Shan Hailson AUDITORS Mr. LO Wing Yat Deloitte Touche Tohmatsu JOINT COMPANY SECRETARY Certified Public Accountants 35/F., One Pacific Place Ms. LEUNG Suet Lun 88 Queensway Mr. ZHAO Dongji Hong Kong AUDIT COMMITTEE SHARE REGISTRAR AND TRANSFER OFFICE Mr. XIE Rong (Chairman) Mr. ZHOU Bajun Computershare Hong Kong Investor Services Limited Mr.